Arrhythmias & electrophysiology
A novel device for temporary cardiac stimulation using permanent pacemaker generators and active-fixation leads: the TEMPACE multicentre prospective study
Authors' conclusion
Temporary cardiac pacing with active-fixation leads using the KronoSafe® adapter is safe and effective, and its use can be extended outside the intensive care unit.
Study context
- Population
- Consecutive patients who underwent implantation of a temporary active-fixation pacemaker, secured with the KronoSafe® adapter, January 2023 to December 2024patients who required temporary cardiac pacing (TCP)
- Participants
- 30 patients
- Outcome
- Indications for TCP
Methodological detailsconsecutive patients, two centres
- Consecutive patients
- Two centres
Main finding
As reported in the abstract
- Atrioventricular block
- 10
- TAVI
- nine
- Alcohol septal ablations
- five
- Slow atrial fibrillations
- two
- Bradycardia-tachycardia syndrome
- two
- Pacemaker infections
- two
Observational data: associations, not effects.
Further findings
- Mean duration of TCP
- 7.8 days
- Maximum
- 22 days
- Time spent in the cardiology ward
- 79.2%
Safety
Complications during TCPAFL
- One complication, due to accidental traction of the system associated with an episode of agitation
- 3%
Original publication
A novel device for temporary cardiac stimulation using permanent pacemaker generators and active-fixation leads: the TEMPACE multicentre prospective study. Eur Heart J Acute Cardiovasc Care. Published 28 August 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →